Thomson Medical granted 3 months extension to restore public float

SGX previously rejected the company’s appeal for an extension.

SGX granted Thomson Medical an additional three months until 10 April 2024, to restore its public float under Rule 723 of the SGX-ST Listing Manual.

The grant comes after the company's appeal on 12 January.

The company also appealed for an extension on 2 January, but SGX rejected the proposed extension.

Thomson Medical’s public shares dipped to 9.98% in September 2023.

SGX gave the healthcare provider an initial three months and an extension of one month to restore their public float.

The company had applied for a grace period to restore its public float thrice.

Follow the link for more news on

Thomson Medical

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia